A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Fernando J. MARTINEZ, Prof.
Weill Cornell Medical College, New York Presbyterian Hospital, 1305 York avenue box 96 NY 10021 USA
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
460 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chiesi Clinical Trial - Site 32502
Buenos Aires, Argentina
- Chiesi Clinical Trial - Site 32510
Buenos Aires, Argentina
- Chiesi Clinical Trial - Site 32515
Buenos Aires, Argentina
- Chiesi Clinical Trial - Site 32565
Buenos Aires, Argentina
- Chiesi Clinical Trial - Site 32514
Ciudad Autonoma Buenos Aires, Argentina
- Chiesi Clinical Trial - Site 32567
Ciudad Autonoma Buenos Aires, Argentina
- Chiesi Clinical Trial - Site 32507
Ciudad Autónoma de Buenos Aire, Argentina
- Chiesi Clinical Trial - Site 32563
Concepción del Uruguay, Argentina
- Chiesi Clinical Trial - Site 32503
Córdoba, Argentina
- Chiesi Clinical Trial - Site 32509
Córdoba, Argentina
- Chiesi Clinical Trial - Site 32501
Florida, Argentina
- Chiesi Clinical Trial - Site 32562
Mar del Plata, Argentina
- Chiesi Clinical Trial - Site 32505
Mendoza, Argentina
- Chiesi Clinical Trial - Site 32511
Mendoza, Argentina
- Chiesi Clinical Trial - Site 32513
Mendoza, Argentina
- Chiesi Clinical Trial - Site 32506
Quilmes, Argentina
- Chiesi Clinical Trial - Site 32553
Rosario, Argentina
- Chiesi Clinical Trial - Site 32508
San Juan Bautista, Argentina
- Chiesi Clinical Trial - Site 32512
San Miguel de Tucumán, Argentina
- Chiesi Clinical Trial - Site 32551
San Miguel de Tucumán, Argentina
- Chiesi Clinical Trial - Site 32561
San Miguel de Tucumán, Argentina
- Chiesi Clinical Trial - Site 32564
San Miguel de Tucumán, Argentina
- Chiesi Clinical Trial - Site 32566
San Rafael, Argentina
- Chiesi Clinical Trial - Site 32556
Santa Fe, Argentina
- Chiesi Clinical Trial - Site 40502
Feldbach, Austria
- Chiesi Clinical Trial - Site 40504
Grieskirchen, Austria
- Chiesi Clinical Trial - Site 40501
Linz, Austria
- Chiesi Clinical Trial - Site 40503
Linz, Austria
- Chiesi Clinical Trial - Site 40505
Wels, Austria
- Chiesi Clinical Trial - Site 70553
Banja Luka, Bosnia and Herzegovina
- Chiesi Clinical Trial - Site 70555
Bihać, Bosnia and Herzegovina
- Chiesi Clinical Trial - Site 70554
Bijeljina, Bosnia and Herzegovina
- Chiesi Clinical Trial - Site 70557
Foca, Bosnia and Herzegovina
- Chiesi Clinical Trial - Site 70556
Gradiska, Bosnia and Herzegovina
- Chiesi Clinical Trial - Site 70560
Mostar, Bosnia and Herzegovina
- Chiesi Clinical Trial - Site 70562
Mostar, Bosnia and Herzegovina
- Chiesi Clinical Trial - Site 70559
Sarajevo, Bosnia and Herzegovina
- Chiesi Clinical Trial - Site 70561
Sarajevo, Bosnia and Herzegovina
- Chiesi Clinical Trial - Site 70551
Travnik, Bosnia and Herzegovina
- Chiesi Clinical Trial - Site 70558
Trebinje, Bosnia and Herzegovina
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Jul 2021
- Primary completion
- 23 Dec 2025
- Completion
- 23 Dec 2025
- Last update posted
- 2 Feb 2026
- Registered enrollment
- 3,973
- Registry id
- NCT04636814
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.